The Murcian tennis player is playing his first Grand Slam final and is already number one in Spanish tennis after beating Tiafoe (6-7, 6-3, 6-1, 6-7 and 6-3).
Carlos Alcaraz will play his first Grand Slam final at the US Open next Sunday. The Spanish tennis player showed that when matches go to five sets he is almost invincible (8 wins and one loss) and confirmed his pass in another epic match that lasted 4 hours and 18 minutes, in which he had to come from behind against Frances Tiafoe in five sets of maximal emotion (6-7, 6-3, 6-1, 6-7 and 6-3).
In the final on Sunday he will meet Casper Ruud, who won his semifinal against the Russian Karen Kachanov and with whom a double prize is played, as the one who wins next to his first Grand Slam becomes number one in world tennis. In addition, Alcaraz is the second youngest finalist in the tournament after Pete Sampras, who won it in 1990 at the age of 19 and one month.
Whatever happens in the grand final, Carlos Alcaraz can already boast that he is the best Spanish tennis player in the ATP ranking, as next Monday he has a 130 point lead over Rafael Nadal.
“In the semi-final you have to give everything, fight to the last ball, it doesn’t matter if you fight for five hours or six,” admitted the Murcian of another five-set win, with a smile on his face. “I will have to control my nerves in my first Grand Slam final, but of course I am very happy and I will enjoy every moment. We’ll see what happens,” he added on the blue track.
Alcalraz already confessed in Spanish that “what I experienced today is unbelievable”. “Three matches of five sets, very long, very demanding,” he added of their round of 16, quarter and semi-finals. “The truth is that I have strength because of you, you encourage me at every point, every ball,” he instructed the audience.
Source: La Verdad
I’m an experienced news author and editor based in New York City. I specialize in covering healthcare news stories for Today Times Live, helping to keep readers informed on the latest developments related to the industry. I have a deep understanding of medical topics, including emerging treatments and drugs, the changing laws that regulate healthcare providers, and other matters that affect public health.
